Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Saint-Cloud, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
FranceStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
FranceStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
FranceStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
FranceStudy of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
FranceStudy of ultevursen treatment in patients with retinitis pigmentosa caused by mutations in USH2A gene exon 13
FranceStudy of tarlatamab alone or with FOLFIRI chemotherapy for patients with advanced digestive system or unknown origin neuroendocrine carcinomas
FranceStudy of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
FranceStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
FranceStudy of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy
FranceLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
FranceStudy of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma and multiple myeloma treatments, including studies of novel therapies like duvelisib for T-cell lymphoma and odronextamab for follicular lymphoma.
Several studies are evaluating combination therapies and comparing new treatment approaches against standard care.
Comprehensive research into various types of breast cancer, with particular focus on hormone receptor-positive and triple-negative variants. Studies include early detection methods and novel therapeutic combinations.
Trials incorporate innovative approaches like ctDNA monitoring and targeted therapies.
Research focusing on targeted therapies for various advanced cancers, including studies of biliary tract cancer and non-small cell lung cancer treatments.
Emphasis on immunotherapy combinations and precision medicine approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
